Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongjingning is a Traditional Chinese Medicine (TCM) herbal formulation developed as a cataplasm (medicated hydrogel patch) by the Shanghai Hospital of Traditional Chinese Medicine. It is specifically designed to treat secondary dysmenorrhea associated with adenomyosis, particularly in patients diagnosed with the blood stasis pattern according to TCM theory. The treatment is applied topically to specific acupuncture points or the lower abdomen, utilizing meridian theory to enhance therapeutic effects. The formulation is intended to promote blood circulation, resolve stasis, and provide analgesic effects. Clinical research has focused on its efficacy as a non-invasive alternative or adjunct to conventional hormonal or surgical treatments for adenomyosis-related pain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tongjingning (Shanghai Municipal Hospital of Traditional Chinese Medicine).